DNTH
Dianthus Therapeutics Inc.
84.90$
-0.6%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 103.2% | 4.2% | 253.6% | 8.7% | 2.1% | 22.5% | 12.2% | 6.0% | 5.3% | 5.9% | 11.4% | 51.3% | 25.0% | – | 16.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 95.8% | 100.0% | 91.3% | 97.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 83.6% | 100.0% | 96.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 615.3% | 836.7% | 1,228.4% | 1,058.1% | 861.5% | 1,921.4% | 1,496.3% | 969.9% | 1,176.1% | 1,991.9% | 2,321.8% | 13,601.6% | 8,204.3% | 21,089.8% | 7,457.5% | 6,397.6% | 9,222.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 188.3% | 173.4% | 485.7% | 257.2% | 944.0% | 1,013.6% | 645.3% | 321.9% | 300.6% | 515.0% | 630.9% | 4,595.3% | 2,069.4% | 3,496.5% | 2,692.9% | 1,781.5% | 2,318.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 803.7% | 1,005.9% | 1,714.1% | 1,306.6% | 1,803.5% | 2,935.0% | 2,141.6% | 1,291.8% | 1,476.6% | 2,506.9% | 2,952.7% | 18,196.9% | 10,273.7% | 24,586.3% | 10,133.9% | 8,179.1% | 11,537.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -703.7% | -910.0% | -1,614.1% | -1,215.3% | -1,705.5% | -2,835.0% | -2,041.6% | -1,191.8% | -1,376.6% | -2,406.9% | -2,852.7% | -18,096.9% | -10,173.7% | -24,486.3% | -10,050.3% | -8,079.1% | -11,441.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 101.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -663.6% | -860.9% | -1,489.3% | -1,149.6% | -1,597.7% | -2,311.4% | -1,573.0% | -945.1% | -1,159.0% | -2,144.8% | -2,537.5% | -16,388.1% | -9,284.1% | 34,473.6% | -8,819.4% | -6,598.6% | -1,570.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -80.4% | -52.8% | 244.8% | 18.5% | -111.1% | 185.6% | -12.2% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -663.6% | -860.9% | -1,489.3% | -1,149.6% | -1,597.7% | -2,311.4% | -1,573.0% | -945.1% | -1,159.0% | -2,144.8% | -2,537.5% | -16,388.1% | -9,284.1% | 34,473.6% | -8,819.4% | -6,598.6% | -1,570.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -662.7% | -856.8% | -1,486.3% | -1,338.9% | -1,595.7% | -2,288.8% | -1,560.8% | -939.1% | -1,153.7% | -2,138.9% | -2,526.1% | -16,336.8% | -9,277.3% | 34,564.8% | -8,803.0% | -6,593.7% | -1,549.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.